Production (Stage)
Cadrenal Therapeutics, Inc.
CVKD
$13.70
-$0.16-1.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.85M | -4.19M | -2.41M | -2.39M | -1.66M |
| Total Depreciation and Amortization | 5.50K | 400.00 | 400.00 | 500.00 | 600.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 548.80K | 763.20K | 299.90K | 193.00K | 162.60K |
| Change in Net Operating Assets | -1.36M | 1.63M | -93.70K | 670.30K | -336.30K |
| Cash from Operations | -4.65M | -1.79M | -2.20M | -1.53M | -1.84M |
| Capital Expenditure | -3.30K | -6.50K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.30K | -6.50K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.06M | 3.62M | 1.53M | 0.00 | 300.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -85.30K | 3.84M | -- | -- | -- |
| Cash from Financing | 1.97M | 7.45M | 1.53M | 0.00 | 300.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.68M | 5.65M | -673.30K | -1.53M | -1.84M |